Scientific Advisory Board members

The current accessible information from this company do not show any records on BDS activities, the most recent recorded event correspond to 2000 activities. On November 14, 2001, their report announced a restructuring process of the Company s Scientific Advisory Board, replacing members with scientists and physicians with experience in cancer, production of therapeutic proteins, preclinical development and clinical trials. That indication for a new orientation and focus to the health sector did not last enough, and soon after, the company disappeared from the SEC (and any other financial) listing. 

The author, Professor Jiri Matousek, PhD, DSc., Dipl. Eng., was working nearly 40 years in R D for Chemical Corps, Medical Services and Civil Protection, inter alia as Head of the Czechoslovak NBC Defence R D Establishment (now Military Technical Institute of Protection, Bmo) and a member of the Czechoslovak Delegation to the Conference on Disarmament in Geneva. He is currently chairman of the OPCW Scientific Advisory Board. 

Jean-Marc Sabatier has a Ph.D. and HDR in biochemistry. He is the director of research at the French Centre National de la Recherche Scientifique (CNRS). He heads a research laboratory (ERT 62) entided Engineering of Therapeutic Peptides at the Universite de la Mediterranee, in Marseilles, France. He also holds the position of a senior director (discovery research — peptides) for a public company in Canada. Dr. Sabatier works in the field of animal toxins, and leads the venom peptide group of the International Neuropeptide Society. He also designs immunomodulatory and antiviral drugs, as well as contributes to the field of peptide and protein engineering. He has contributed more than 100 scientific articles, 180 communications, and 43 patents. He is a member of several scientific advisory boards of journals (e.g.. Peptides, Biochemical Journal), and has reviewed articles submitted for publication in more than 30 specialized international journals. 

Danilo Corradini is research director at the Institute of Chemical Methodologies of the Italian National Research Council (CNR) and a member of the General Scientific Advisory Board of CNR. His involvement in separation science started in 1976 with his research work on chromatography and electrophoresis for his PhD studies in chemistry, which was carried out at Sapienza University of Rome, Italy, under the direction of Michael Lederer, founder and first editor of the Journal of Chromatography. In 1983-1984, he worked with Csaba Horvath, the pioneer of HPLC, at the Department of Chemical Engineering at Yale University, New Haven, Connecticut, where he initiated his first investigations on the HPLC of proteins and peptides, which he continued at the Institute of Chromatography of CNR after he returned to Italy. 

Dr. Mesilaakso is currently Acting Director of the Finnish Institute for Verification of the Chemical Weapons Convention (VERIFTN former CW Project) at the University of Helsinki. Before this, he worked at VERIFIN as a Research Scientist, Quality Manager and Research Director. He is a member of the Finnish National Authority of the CWC, a member of the Scientific Advisory Board for the Defense of Finland, and a member of the OPCW Validation Group for data evaluation to the OPCW Central Analytical Database. 

I would take this opportunity to thank the members of the Organising Committee and of the Scientific Advisory Board for all their efforts in preparing this meeting and also the IAEA for co-sponsoring the meeting which, I am sure, will be a successful one. 

The members of the Scientific Advisory Boards for the projects, whose direction and high-level steering has been an important contribution to their success and indirectly to the results in this book Prof. Bernard Courtois, Prof. Hugo De Man, Prof. Patrick Dewilde, Prof. Jochen Jess, Prof. Manfred Glesner, Prof. Costas Goutis, Prof. Ole Olesen, Prof. Lars Philipson, Prof. Patrice Quinton, Prof. Yves Robert, and Prof. Joos Vandewalle. 

In consultation with the members of the Scientific Advisory Board, the Director-General may establish temporary working groups of scientific experts to provide recommendations on specific issues within a specific time frame, in accordance with paragraph 45 of Article VIII of the Convention. 

The Scientific Advisory Board shall appoint by consensus a Chair and a Vice-Chair by annual election from among its members. 

The Director-General, in consultation with the Chair of the Scientific Advisory Board, shall notify each member of the Board of a planned meeting, stating the purpose, the venue, the opening date and the expected duration of the meeting, as far in advance as possible, but at... 

A temporary working group shall be chaired by a member of the Scientific Advisory Board appointed for that purpose by the Chair of the Board, with the approval of the Director-General. 

If any member of the Scientific Advisory Board or of a temporary working group is aware of any activity of another member of the Board or working group that could affect his or her impartiality or appearance of impartiality, he or she shall notify such activity to the Director-General. 

The purpose of this Code of Conduct is to enhance confidence in the integrity of the members of the Scientific Advisory Board and of the temporary working groups as independent experts serving in their individual capacity. 

Members of the Scientific Advisory Board and the temporary working groups shall be bound by the provisions of the Confidentiality Annex to the Convention, and of the OPCW Policy on Confidentiality, and shall, when using confidential documents, apply the OPCW Manual of Confidentiality Procedure, mutatis mutandis. 

The Director-General shall ensure that meetings of the Scientific Advisory Board and temporary working groups in which confidential information is considered receive support only from those staff members of the Technical Secretariat who have been specifically cleared by the Director-General. 

The Director-General may dismiss any member of the Scientific Advisory Board for just cause, such as a breach of confidentiality, or a gross breach of the code of conduct detailed in Rule 8 above. In case of dismissal, the Director-General shall communicate in writing the reasons for the dismissal to the Board members, including the Board member concerned. Thereafter, the Director-General will report any such dismissal to the Conference of the States Parties, as appropriate. 

In view of my obligation to carry out faithfully and conscientiously the tasks entrusted to me during my term (or terms) as a member of the Scientific Advisory Board or as a member of a temporary working group, I further undertake that for the duration of that term (or terms), I shall ... 

CONFIRMATION On the expiration of my term or consecutive terms as member of the OPCW Scientific Advisory Board or member of a temporary working group, I confirm my understanding that the obligations relating to confidentiality continue to apply without time limitation in the future. 

Member, Scientific Advisory Board, NAPRALERI MEDFLOR METMAP. 

It is important to have a cross-functional team (engineering, regulatory, QA) perform the review. At least one member of the design review should be independent (i.e., a person who is not involved in the project). Members of the scientific advisory board and experienced, technically astute engineers independent of the development organization are priceless to weigh in and should be included. 

He is author of approximately 100 scientific publications and of a textbook about chemical sensors which has been translated in several languages. During his active teaching period, he has been advisory board member of several scientific journals and also of research organisatiOTis. 

---